Borchard G - Search Results

1

Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.

Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE. Borges O, et al. Among authors: borchard g. Eur J Pharm Biopharm. 2008 Jun;69(2):405-16. doi: 10.1016/j.ejpb.2008.01.019. Epub 2008 Jan 31. Eur J Pharm Biopharm. 2008. PMID: 18364251 Free article.

2

Intranasal Administration of Novel Chitosan Nanoparticle/DNA Complexes Induces Antibody Response to Hepatitis B Surface Antigen in Mice.

Lebre F, Borchard G, Faneca H, Pedroso de Lima MC, Borges O. Lebre F, et al. Among authors: borchard g. Mol Pharm. 2016 Feb 1;13(2):472-82. doi: 10.1021/acs.molpharmaceut.5b00707. Epub 2016 Jan 12. Mol Pharm. 2016. PMID: 26651533

3

Preparation of coated nanoparticles for a new mucosal vaccine delivery system.

Borges O, Borchard G, Verhoef JC, de Sousa A, Junginger HE. Borges O, et al. Among authors: borchard g. Int J Pharm. 2005 Aug 11;299(1-2):155-66. doi: 10.1016/j.ijpharm.2005.04.037. Int J Pharm. 2005. PMID: 15998569

4

Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.

Borges O, Cordeiro-da-Silva A, Romeijn SG, Amidi M, de Sousa A, Borchard G, Junginger HE. Borges O, et al. Among authors: borchard g. J Control Release. 2006 Sep 12;114(3):348-58. doi: 10.1016/j.jconrel.2006.06.011. Epub 2006 Jun 16. J Control Release. 2006. PMID: 16905219

5

Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers.

Borges O, Borchard G, de Sousa A, Junginger HE, Cordeiro-da-Silva A. Borges O, et al. Among authors: borchard g. Int J Pharm. 2007 Jun 7;337(1-2):254-64. doi: 10.1016/j.ijpharm.2007.01.021. Epub 2007 Jan 20. Int J Pharm. 2007. PMID: 17317051

6

Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.

Borges O, Tavares J, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A. Borges O, et al. Among authors: borchard g. Eur J Pharm Sci. 2007 Dec;32(4-5):278-90. doi: 10.1016/j.ejps.2007.08.005. Epub 2007 Aug 15. Eur J Pharm Sci. 2007. PMID: 17884394

7

Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.

Borges O, Silva M, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A. Borges O, et al. Among authors: borchard g. Int Immunopharmacol. 2008 Dec 20;8(13-14):1773-80. doi: 10.1016/j.intimp.2008.08.013. Epub 2008 Sep 16. Int Immunopharmacol. 2008. PMID: 18801462

8

Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles.

Jesus S, Soares E, Costa J, Borchard G, Borges O. Jesus S, et al. Among authors: borchard g. Int J Pharm. 2016 May 17;504(1-2):59-69. doi: 10.1016/j.ijpharm.2016.03.013. Epub 2016 Mar 11. Int J Pharm. 2016. PMID: 26976502

9

Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen.

Jesus S, Soares E, Borchard G, Borges O. Jesus S, et al. Among authors: borchard g. Nanomedicine (Lond). 2017 Oct;12(19):2335-2348. doi: 10.2217/nnm-2017-0138. Epub 2017 Sep 4. Nanomedicine (Lond). 2017. PMID: 28868964

10

Association of chitosan and aluminium as a new adjuvant strategy for improved vaccination.

Lebre F, Bento D, Ribeiro J, Colaço M, Borchard G, de Lima MCP, Borges O. Lebre F, et al. Among authors: borchard g. Int J Pharm. 2017 Jul 15;527(1-2):103-114. doi: 10.1016/j.ijpharm.2017.05.028. Epub 2017 May 15. Int J Pharm. 2017. PMID: 28522427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters